147 related articles for article (PubMed ID: 11923690)
1. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report.
Aranda JM; Scornik JC; Normann SJ; Lottenberg R; Schofield RS; Pauly DF; Miles M; Hill JA; Sleasman JW; Skoda-Smith S
Transplantation; 2002 Mar; 73(6):907-10. PubMed ID: 11923690
[TBL] [Abstract][Full Text] [Related]
2. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab.
Keren A; Hayes HM; O'Driscoll G
Transplant Proc; 2006 Jun; 38(5):1520-2. PubMed ID: 16797348
[TBL] [Abstract][Full Text] [Related]
3. Treatment of humoral rejection with rituximab.
Garrett HE; Groshart K; Duvall-Seaman D; Combs D; Suggs R
Ann Thorac Surg; 2002 Oct; 74(4):1240-2. PubMed ID: 12400781
[TBL] [Abstract][Full Text] [Related]
4. Low-dose rituximab therapy for antibody-mediated rejection in a highly sensitized heart-transplant recipient.
Aggarwal A; Pyle J; Hamilton J; Bhat G
Tex Heart Inst J; 2012; 39(6):901-5. PubMed ID: 23304051
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
6. New treatments for acute humoral rejection of kidney allografts.
Venetz JP; Pascual M
Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
[TBL] [Abstract][Full Text] [Related]
7. Treatment of vascular rejection with rituximab in cardiac transplantation.
Garrett HE; Duvall-Seaman D; Helsley B; Groshart K
J Heart Lung Transplant; 2005 Sep; 24(9):1337-42. PubMed ID: 16143254
[TBL] [Abstract][Full Text] [Related]
8. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
[TBL] [Abstract][Full Text] [Related]
9. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
10. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate.
Vega J; Goecke H; Carrasco A; Escobar C; Escobar M; Espinosa R; Méndez G; de Los Ángeles Rodríguez M
Clin Exp Nephrol; 2011 Apr; 15(2):308-11. PubMed ID: 21152944
[TBL] [Abstract][Full Text] [Related]
12. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
13. Impact of rituximab therapy for treatment of acute humoral rejection.
Kaposztas Z; Podder H; Mauiyyedi S; Illoh O; Kerman R; Reyes M; Pollard V; Kahan BD
Clin Transplant; 2009; 23(1):63-73. PubMed ID: 19200217
[TBL] [Abstract][Full Text] [Related]
14. Early and late humoral rejection: a clinicopathologic entity in two times.
Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation.
Astor TL; Galantowicz M; Phillips A; Palafox J; Baker P
Am J Transplant; 2009 Feb; 9(2):409-12. PubMed ID: 19067668
[TBL] [Abstract][Full Text] [Related]
16. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
[TBL] [Abstract][Full Text] [Related]
17. Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.
Loupy A; Suberbielle-Boissel C; Zuber J; Anglicheau D; Timsit MO; Martinez F; Thervet E; Bruneval P; Charron D; Hill GS; Nochy D; Legendre C
Transplantation; 2010 Jun; 89(11):1403-10. PubMed ID: 20386362
[TBL] [Abstract][Full Text] [Related]
18. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation.
Usuda M; Fujimori K; Koyamada N; Fukumori T; Sekiguchi S; Kawagishi N; Akamatsu Y; Enomoto Y; Satoh K; Satoh A; Ishida K; Moriya T; Satomi S
Transplantation; 2005 Jan; 79(1):12-6. PubMed ID: 15714163
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
20. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
